chr19-3595705-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000375190.10(TBXA2R):c.1015C>T(p.Arg339Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000234 in 1,591,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R339H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000375190.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.1015C>T | p.Arg339Cys | missense_variant | 3/3 | ENST00000375190.10 | NP_001051.1 | |
TBXA2R | XM_011528214.3 | c.1015C>T | p.Arg339Cys | missense_variant | 4/4 | XP_011526516.1 | ||
TBXA2R | NM_201636.3 | c.983+32C>T | intron_variant | NP_963998.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.1015C>T | p.Arg339Cys | missense_variant | 3/3 | 1 | NM_001060.6 | ENSP00000364336 | P1 | |
TBXA2R | ENST00000589966.1 | c.626C>T | p.Ala209Val | missense_variant | 2/2 | 1 | ENSP00000468145 | |||
TBXA2R | ENST00000411851.3 | c.983+32C>T | intron_variant | 2 | ENSP00000393333 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000136 AC: 28AN: 206222Hom.: 0 AF XY: 0.0000982 AC XY: 11AN XY: 111992
GnomAD4 exome AF: 0.000243 AC: 350AN: 1439216Hom.: 0 Cov.: 66 AF XY: 0.000258 AC XY: 184AN XY: 713590
GnomAD4 genome AF: 0.000145 AC: 22AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 16, 2024 | Variant summary: TBXA2R c.1015C>T (p.Arg339Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 206222 control chromosomes. This frequency does not allow conclusions about variant significance. To our knowledge, no occurrence of c.1015C>T in individuals affected with Bleeding Diathesis Due To Thromboxane Synthesis Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2389230). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.1015C>T (p.R339C) alteration is located in exon 3 (coding exon 2) of the TBXA2R gene. This alteration results from a C to T substitution at nucleotide position 1015, causing the arginine (R) at amino acid position 339 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 06, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 339 of the TBXA2R protein (p.Arg339Cys). This variant is present in population databases (rs202067474, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TBXA2R-related conditions. ClinVar contains an entry for this variant (Variation ID: 2389230). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at